Description

PANTAS-L |( Pantoprazole 40mg & Levosulpiride 75mg SR )

PANTAS-L: Advanced Dual Therapy for Acid Reflux and Functional Dyspepsia

Gastrointestinal disorders such as acid reflux, gastritis, and functional dyspepsia are increasingly common in modern lifestyles. These conditions often require a treatment approach that addresses both acid control and gut motility. PANTAS-L, a powerful combination of Pantoprazole 40mg and Levosulpiride 75mg SR, delivers comprehensive relief by reducing stomach acid and enhancing gastric emptying. Formulated by Texas Pharmaceuticals Pvt. Ltd., PANTAS-L is trusted by physicians for its dual-action efficacy and long-lasting results.

Composition & Strength

• Pantoprazole 40 mg (Enteric-Coated Tablet)

• Levosulpiride 75 mg SR (Sustained Release)

Therapeutic Uses & Indications

PANTAS-L is indicated in the management of:

• Gastroesophageal Reflux Disease (GERD)
• Chronic and acute gastritis
• Functional dyspepsia
• Non-ulcer dyspepsia
• Hyperacidity with delayed gastric emptying
• Irritable bowel syndrome (IBS) with bloating and fullness
• Peptic ulcer disease (as adjunct therapy)

Mechanism of Action

Pantoprazole (40 mg)

A proton pump inhibitor (PPI) that blocks the H+/K+ ATPase enzyme in gastric parietal cells, thereby suppressing the final step in acid production. It provides long-lasting relief from acidity, heartburn, and mucosal damage.

Levosulpiride (75 mg SR)

An atypical prokinetic and antipsychotic agent, Levosulpiride works by blocking dopamine D2 receptors in the gastrointestinal tract. This enhances gastric motility, accelerates gastric emptying, and alleviates symptoms such as nausea, bloating, and postprandial fullness.

 Benefits of PANTAS-L

• Dual mechanism: Controls acid and improves gut motility

• SR formulation of Levosulpiride for sustained action

• Effective in GERD with dysmotility symptoms

• Relieves bloating, belching, and abdominal discomfort

• Promotes healing of erosive esophagitis and gastric inflammation

Packaging Details

• Pack Size: 10×10 Alu-Alu

• Dosage Form: Bilayer tablet (EC + SR)

• Route: Oral

• Storage: Store in a cool, dry place away from sunlight
  
  

Scientific Backing

Studies have shown that combining a PPI with a prokinetic agent leads to greater symptom relief in patients with refractory GERD and functional dyspepsia, compared to monotherapy. Levosulpiride’s unique ability to address both psychological and GI symptoms makes it a preferred choice in stress-induced dyspeptic conditions.

Why Choose PANTAS-L from Texas Pharmaceuticals?

✔ Clinically proven ingredients
✔ High-quality bilayer technology for dual release
✔ Excellent patient compliance
✔ Trusted by gastroenterologists and physicians
✔ Backed by GMP-certified manufacturing standards

Buy Now / Partner With Us

Join hands with Texas Pharmaceuticals Pvt. Ltd., one of India’s fastest-growing PCD pharma companies. Whether you’re a wholesaler, distributor, or doctor looking for a reliable supply partner, we have you covered.

 Contact Now: +91-7056756400, 8146661517, 7206074700
Email: markketing@texasusa.in
Website: https://www.texasusa.in

Conclusion

PANTAS-L offers a comprehensive solution for patients suffering from acid reflux, indigestion, and motility-related GI disorders. Its powerful combination of Pantoprazole and Levosulpiride SR ensures fast relief and long-term gastric comfort, making it a go-to product for physicians and healthcare providers.